The aim is to obtain an effective clinical tool by means of metabolomics and transcriptomics techniques to evaluate the possible appearance of respiratory complications in patients with COVID-19. This tool will enable patients to be stratified according to their risk of respiratory deterioration, which could have a favourable impact on their prognosis, assisting in clinical and therapeutic decisions, and optimising the use of available resources.
The results of the project will provide mechanistic information on the development of acute respiratory distress syndrome in COVID-19 sufferers.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact